S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

RPTX Repare Therapeutics Inc

1.27

-0.01 (-0.78%)

Pre Market

Last Updated: 03:08:09

Delayed by 15 minutes

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

null

Repare Therapeutics (NASDAQ:RPTX)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Repare Therapeutics Charts.

Repare Therapeutics (NASDAQ:RPTX)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Repare Therapeutics Charts.

Repare Therapeutics Inc News

Form 8-K - Current report
Friday 10 January 2025 (6 days ago) • Edgar (US Regulatory)

Repare Therapeutics Announces Portfolio Re-Prioritization, Partnering Initiatives and Cost Reductions
Thursday 9 January 2025 (7 days ago) • Business Wire

Form 8-K - Current report
Thursday 12 December 2024 (1 month ago) • Edgar (US Regulatory)

Repare Therapeutics Announces Positive Results of the Lunresertib and Camonsertib Combination from the MYTHIC Phase 1 Gynecologic Expansion Clinical Trial
Thursday 12 December 2024 (1 month ago) • Business Wire

Repare Therapeutics to Host Webcast to Report Data from the Lunresertib and Camonsertib Combination Phase 1 MYTHIC Clinical Trial
Tuesday 10 December 2024 (1 month ago) • Business Wire

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

Repare Therapeutics Announces Agreement with the US National Cancer Institute to Advance the Development of Camonsertib
Tuesday 12 November 2024 (2 months ago) • Business Wire

Form 424B5 - Prospectus [Rule 424(b)(5)]
Thursday 7 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 7 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 7 November 2024 (2 months ago) • Edgar (US Regulatory)

Repare Therapeutics Provides Business and Clinical Update and Reports Third Quarter 2024 Financial Results
Thursday 7 November 2024 (2 months ago) • Business Wire

More Repare Therapeutics Inc News Articles

Good Vibrations Shoes (PK)

Moon Equity (PK)

Brookmount Explorations (PK)

Decentral Life (PK)

Kraig Biocraft Laborator... (QB)

Enanta Pharmaceuticals

Tonix Pharmaceuticals

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions